CLINICAL_TRIALS
trial_result
· 2014-10-27
Clinical Trial Update: Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome [Phase 3]
Summary
Phase 3 trial comparing T2750 to Vismed for moderate to severe dry eye disease, with results reported in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Laboratoires Thea | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED | Results posted: 2014-10-27